Search

Your search keyword '"Grandits, Greg"' showing total 237 results

Search Constraints

Start Over You searched for: Author "Grandits, Greg" Remove constraint Author: "Grandits, Greg"
237 results on '"Grandits, Greg"'

Search Results

1. Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.

2. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

3. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

4. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

5. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

6. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

7. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

8. Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease

11. Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.

12. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

14. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial

15. Abstract P220: Effects Of Orthostatic Hypotension On Intensive Blood Pressure Treatment With Respect To All-cause Mortality: An Individual-level Meta-analysis

16. Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?

18. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19:a randomised, double-blind, phase 3 trial

19. Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

25. Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial

26. Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?

27. The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa

29. Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies

30. Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension

31. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis

33. Abstract MP36: Effects Of Intensive Blood Pressure Treatment On Orthostatic Hypotension: An Individual-level Meta-analysis

35. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

38. Treatment of mild hypertension study: final results

40. Spontaneous virologic suppression in HIV controllers is independent of delayed-type hypersensitivity test responsiveness

41. Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study

42. Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study

45. Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial

46. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial

48. Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial

50. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial

Catalog

Books, media, physical & digital resources